These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21332036)

  • 21. The efficacy of probiotics in IBS.
    Quigley EM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nutritional factors and nutritional therapy for irritable bowel syndrome--what is worthwhile?].
    Wächtershäuser A; Stein JM
    Z Gastroenterol; 2008 Mar; 46(3):279-91. PubMed ID: 18322884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irritable bowel syndrome - The role of complementary medicines in treatment.
    Pirotta M
    Aust Fam Physician; 2009 Dec; 38(12):966-8. PubMed ID: 20369148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM; Flourie B
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
    Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of capsule 'UB03' containing potential probiotic strains for the treatment of patients with irritable bowel syndrome.
    Sudha MR; Sawant P
    Benef Microbes; 2011 Sep; 2(3):229-33. PubMed ID: 21986362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial.
    Bittner AC; Croffut RM; Stranahan MC; Yokelson TN
    Clin Ther; 2007 Jun; 29(6):1153-60. PubMed ID: 17692729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
    Cash BD
    Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
    Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options in irritable bowel syndrome.
    Farthing MJ
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
    Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
    Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
    Madden JA; Hunter JO
    Br J Nutr; 2002 Sep; 88 Suppl 1():S67-72. PubMed ID: 12215182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
    Diaz Ferrer J; Parra V; Bendaño T; Montes P; Solorzano P
    Rev Gastroenterol Peru; 2012; 32(4):387-93. PubMed ID: 23307089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.